Rotavirus vaccines [1]

New England Journal of Medicine

Volumn 354, Issue 16, 2006, Pages 1747-

  Molinaro, Giuseppe A ^a   Lee, Dean A ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; ROTAVIRUS VACCINE; LIVE VACCINE; ORAL POLIOMYELITIS VACCINE;

B LYMPHOCYTE; CLINICAL TRIAL; DEVELOPING COUNTRY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNITY; LETTER; MORTALITY; PRIORITY JOURNAL; ROTAVIRUS; SEROTYPE; T LYMPHOCYTE; VACCINATION; VIRUS INFECTION; VIRUS STRAIN; VIRUS TRANSMISSION; CLASSIFICATION; DEVELOPED COUNTRY; GASTROENTERITIS; IMMUNOLOGY; INFANT; NOTE; SEROTYPING; VIROLOGY; AGE; INTUSSUSCEPTION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; POLIOMYELITIS; RECIPIENT;

DEVELOPED COUNTRIES; GASTROENTERITIS; HUMANS; INFANT; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SEROTYPING; VACCINES, ATTENUATED; AGE FACTORS; INTUSSUSCEPTION; IMMUNOCOMPROMISED HOST;

EID: 33645847226     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc060253     Document Type: Letter

References (4)

1. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22.
2. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33.
3. Francis T Jr. Influenza: the new acquayantance. Ann Intern Med 1953;39:203-21.
4. Klenerman P, Zinkernagel RM. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998;394:482-5.